sulpiride has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (30.77) | 18.7374 |
1990's | 7 (53.85) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crossman, AR; Graham, WC; Hill, DR; Sambrook, MA; Woodruff, GN | 1 |
Bruno, JP; Hadjiconstantinou, M; Weihmuller, FB | 2 |
Bédard, PJ; Boucher, R | 1 |
Hirata, Y; Nagatsu, T | 1 |
Chong, PN; Jenner, P; Marsden, CD; Oertel, WH; Temlett, JA | 1 |
Akai, T; Kuno, S; Mizuta, E; Ozawa, M; Yamaguchi, M | 1 |
Holdup, D; Liptrot, J; Phillipson, O | 1 |
Bodis-Wollner, I; Tagliati, M | 1 |
Hadjiconstantinou, M; Hubble, JP; Neff, NH; Sylvia, CP; Wemlinger, TA | 1 |
Earl, CD; Kruk, ZL; Kupsch, A; Oertel, WH; Sautter, J; Xie, J | 1 |
Bubl, B; Feuerstein, TJ; Hubbe, U; Huethe, F; Jackisch, R; Löffler, M; McIntosh, JM | 1 |
Behnisch, T; Chen, Y; Huang, Y; Zhu, G; Zhuang, Y | 1 |
13 other study(ies) available for sulpiride and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Benzodiazepinones; Cholecystokinin; Devazepide; Indicators and Reagents; Iodine Radioisotopes; Macaca fascicularis; Mazindol; Parkinson Disease, Secondary; Prosencephalon; Receptors, Cholecystokinin; Sincalide; Substantia Nigra; Succinimides; Sulpiride; Tegmentum Mesencephali; Tritium | 1991 |
Dopamine receptors and sensorimotor behavior in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arousal; Benzazepines; Discrimination Learning; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Orientation; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1990 |
Effect of D1 receptor stimulation in normal and MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Ergolines; Female; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride | 1989 |
Dissociation between biochemical and behavioral recovery in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Interactions; Haloperidol; Male; Mice; Phenylacetates; Psychomotor Performance; Sulpiride; Time Factors | 1989 |
Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Hydroxylation; In Vitro Techniques; Male; Nomifensine; Nucleus Accumbens; Pyridines; Rats; Rats, Inbred Strains; Sulpiride; Tyrosine; Tyrosine 3-Monooxygenase | 1985 |
The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Callitrichinae; Dopamine Antagonists; Dose-Response Relationship, Drug; Indoles; Motor Activity; Parkinson Disease, Secondary; Phenanthridines; Pyridines; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride | 1988 |
Behavioral involvement of central dopamine D1 and D2 receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Macaca fascicularis; Parkinson Disease, Secondary; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Time Factors | 1995 |
1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biopterins; Chromatography, High Pressure Liquid; Clorgyline; Corpus Striatum; Dopamine; Isoquinolines; Monoamine Oxidase; NAD; Nerve Tissue Proteins; Nomifensine; Parkinson Disease; Rats; Selegiline; Sulpiride; Synaptosomes; Tyrosine 3-Monooxygenase | 1994 |
The visual system in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Contrast Sensitivity; Dopamine; Electroencephalography; Electroretinography; Fourier Analysis; Humans; Macaca fascicularis; Macaca mulatta; Motion Perception; Orientation; Parkinson Disease; Parkinson Disease, Secondary; Pattern Recognition, Visual; Receptors, Dopamine; Receptors, Dopamine D2; Retina; Signal Processing, Computer-Assisted; Sulpiride | 1993 |
Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Pyridoxal Phosphate; Receptors, Dopamine; Reserpine; Sulpiride; Time Factors | 1993 |
Pharmacological characterisation of dopamine overflow in the striatum of the normal and MPTP-treated common marmoset, studied in vivo using fast cyclic voltammetry, nomifensine and sulpiride.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Caudate Nucleus; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electric Stimulation; Electrochemistry; Female; Male; Medial Forebrain Bundle; Nomifensine; Putamen; Reference Values; Sulpiride; Tyrosine 3-Monooxygenase | 1998 |
Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adolescent; Adult; Aged; Alkaloids; Analysis of Variance; Animals; Autoreceptors; Azocines; Calcium; Child; Child, Preschool; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Feedback; Female; Fluvoxamine; Humans; In Vitro Techniques; Isoxazoles; Male; Maprotiline; Mice; Middle Aged; Neocortex; Nicotine; Nicotinic Antagonists; Potassium; Pyrrolidines; Quinolizines; Rats; Receptors, Nicotinic; Sulpiride; Time Factors; Tritium | 2006 |
MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzazepines; Biophysics; Dopamine Antagonists; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Neuronal Plasticity; Neurons; Neurotoxins; Patch-Clamp Techniques; Quinoxalines; Receptors, Dopamine; Sodium Channel Blockers; Sulpiride; Tetrodotoxin; Time Factors; Valine | 2012 |